-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JAWOdQQG8EraPVxQ2V/nYNs3If+g+UFrd27zY2tGe8ABq9DFcxhnnnMEDdGefSbh iF1Xns1UYBmvm6wGEdWe5Q== 0001432580-10-000001.txt : 20100317 0001432580-10-000001.hdr.sgml : 20100317 20100316182103 ACCESSION NUMBER: 0001432580-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100317 DATE AS OF CHANGE: 20100316 EFFECTIVENESS DATE: 20100317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NUON THERAPEUTICS INC CENTRAL INDEX KEY: 0001432580 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-117069 FILM NUMBER: 10686915 BUSINESS ADDRESS: STREET 1: 1840 GATEWAY DRIVE STREET 2: SUITE 200 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650-208-3478 MAIL ADDRESS: STREET 1: 1840 GATEWAY DRIVE STREET 2: SUITE 200 CITY: SAN MATEO STATE: CA ZIP: 94404 D 1 primary_doc.xml X0603 D LIVE 0001432580 NUON THERAPEUTICS INC 2755 Campus Drive Suite 175 SAN MATEO CA 94403 650-645-1800 DELAWARE None None Corporation true 2007 Helen Jenkins c/o Nuon Therapeutics, Inc. 2755 Campus Drive, Suite 175 San Mateo CA 94403 Executive Officer Arlene Morris c/o Affymax, Inc. 4001 Miranda Avenue Palo Alto CA 94304 Executive Officer Director Kim Kamdar c/o Domain Associates 12481 High Bluff Drive, Suite 150 San Diego CA 92130 Director Joshua Funder c/o GBS Venture Partners Level 5, 71 Collins Street Melbourne C3 3000 Director Robert More c/o Frazier Healthcare Ventures 70 Willow Rd, Suite 200 Menlo Park CA 94025 Director Michael Kitt c/o Nuon Therapeutics, Inc. 2755 Campus Drive, Suite 175 San Mateo CA 94403 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2010-03-03 false true false 1 6125766 6053189 72577 Total Offering Amount: $6,125,766.59, Total Amount Sold: $6,053,189.10, Total Remaining to be sold: $72,577.49 false 6 0 0 0 false NUON THERAPEUTICS INC /s/ Helen Jenkins Helen Jenkins Executive Vice President, CFO and COO 2010-03-15 -----END PRIVACY-ENHANCED MESSAGE-----